Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 57 Records) |
| Query Trace: Neoplasms and SLCO1B1[original query] |
|---|
| Explaining Ethnic Variability of Transporter Substrate Pharmacokinetics in Healthy Asian and Caucasian Subjects with Allele Frequencies of OATP1B1 and BCRP: A Mechanistic Modeling Analysis. Clinical pharmacokinetics 2017 Jun . Li Rui, Barton Hugh |
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.
Breast cancer research and treatment 2017 Apr . Dudenkov Tanda M, Ingle James N, Buzdar Aman U, Robson Mark E, Kubo Michiaki, Ibrahim-Zada Irada, Batzler Anthony, Jenkins Gregory D, Pietrzak Tracy L, Carlson Erin E, Barman Poulami, Goetz Matthew P, Northfelt Donald W, Moreno-Aspita Alvaro, Williard Clark V, Kalari Krishna R, Nakamura Yusuke, Wang Liewei, Weinshilboum Richard |
| Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study. BMC cancer 2017 Dec 17 (1): 901. Falkowski Sabrina, Woillard Jean-Baptiste, Postil Deborah, Tubiana-Mathieu Nicole, Terrebonne Eric, Pariente Antoine, Smith Denis, Guimbaud Rosine, Thalamas Claire, Rouguieg-Malki Koukeb, Marquet Pierre, Picard Nicol |
| Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer. Integrative cancer therapies 2018 9 17 (4): 1109-1114. Lu Hongyang, Qin Jing, Han Na, Xie Fajun, Gong Lei, Li Chengh |
| Influence of SLCO1B1 in gastric cancer patients treated with EOF chemotherapy. Oncology letters 2018 Oct 16 (4): 4489-4497. Feng Wanjing, Liu Xin, Zhao Xiaoying, Huang Mingzhu, Guo Weijian, Yin Jiliang, Chen Zhiyu, Zhu Xiaodo |
| SLCO1B1 Polymorphism Is a Drug Response Predictive Marker for Advanced Pancreatic Cancer Patients Treated With Gemcitabine, S-1, or Gemcitabine Plus S-1. Pancreas 0 47 (5): 637-642. Sato Yasunori, Ueno Hideki, Ioka Tatsuya, Ohkawa Shinichi, Ikeda Masafumi, Shimamura Tomotaka, Tsuji Akihito, Tsuchiya Yoshiaki, Furuse Junji, Ishii Hiroshi, Furuya Ken, Iguchi Haruo, Saito Yoshihiro, Kaniwa Nahoko, Sawada Jun-Ichi, Sakamoto Hiromi, Sekine Akihiro, Okusaka Takuji, Yoshida Teruhiko, |
| Effect of UGT, SLCO, ABCB and ABCC polymorphisms on irinotecan toxicity. Medicina clinica 2018 Feb . García Gil Sara, Ramos Díaz Ruth, Nazco Casariego Gloria Julia, Llanos Muñoz Marta, Viña Romero Maria Micaela, Martín Calero Braulio, Pérez Pérez Jose Antonio, Gutiérrez Nicolás Fernan |
| Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine. Tumori 2018 12 106 (2): 87-94. Paulík Adam, Nekvindová Jana, Filip Stanisl |
| Effects of ABCC2 and SLCO1B1 Polymorphisms on Treatment Responses in Thai Metastatic Colorectal Cancer Patients Treated with Irinotecan-Based Chemotherapy. Asian Pacific journal of cancer prevention : APJCP 2018 Oct 19 (10): 2757-2764. Treenert Apatsara, Areepium Nutthada, Tanasanvimon Suebpo |
| Assessment of Transporter Polymorphisms as a Factor in a BCRP Drug Interaction Study With Lanabecestat. Journal of clinical pharmacology 2019 Aug . Willis Brian A, Andersen Scott W, Ayan-Oshodi Mosun, James Douglas E, Liffick Emily, Hillgren Kathleen, Guo Yingying, Monk Scott |
| Bilirubin and risk of ischemic heart disease in Korea: a two-sample Mendelian randomization study.
Epidemiology and health 2019 41 e2019034. Jeon Christina, Lee Ji-Young, Lee Sun Ju, Jung Keum Ji, Kimm Heejin, Jee Sun |
| Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole. Pharmacogenomics 2019 6 20 (8): 571-580. Dempsey Jacqueline M, Kidwell Kelley M, Gersch Christina L, Pesch Andrea M, Desta Zeruesenay, Storniolo Anna Maria, Stearns Vered, Skaar Todd C, Hayes Daniel F, Henry N Lynn, Rae James M, Hertz Daniel |
| Pharmacogenetic Analysis of OATP1B1, UGT1A1, and BCRP Variants in Relation to the Pharmacokinetics of Letermovir in Previously Conducted Clinical Studies. Journal of clinical pharmacology 2019 Apr . Kobie Julie, Guo Zifang, Cho Carolyn R, Menzel Karsten, McCrea Jacqueline B, Blanchard Rebecca, Shaw Peter |
| Association between SLCO1B1 rs4149056 and tegafur-uracil-induced hepatic dysfunction in breast cancer. Pharmacogenomics 2019 Feb . Kamio Hidenori, Uchiyama Toshitaka, Kanno Hitoshi, Onoe Yoshiko, Saito Kayoko, Kameoka Shingo, Kamio Takako, Okamoto Takahi |
| Genetic Variation in Steroid and Xenobiotic Metabolizing Pathways and Enterolactone Excretion Before and After Flaxseed Intervention in African American and European American Women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Feb 28 (2): 265-274. Chang Huiru, Yao Song, Tritchler David, Hullar Meredith A, Lampe Johanna W, Thompson Lilian U, McCann Susan |
| Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects. Scientific reports 2019 12 9 (1): 19410. Kim Yun, Yoon Seonghae, Choi Yewon, Yoon Seo Hyun, Cho Joo-Youn, Jang In-Jin, Yu Kyung-Sang, Chung Jae-Yo |
| Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin. Acta oncologica (Stockholm, Sweden) 2020 5 59 (9): 1009-1015. Ahern Thomas P, Damkier Per, Feddersen Søren, Kjærsgaard Anders, Lash Timothy L, Hamilton-Dutoit Stephen, Lythjohan Cathrine Bredal, Ejlertsen Bent, Christiansen Peer M, Cronin-Fenton Deirdre |
| SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population. Pharmacogenomics and personalized medicine 2020 10 13 521-530. Rattanacheeworn Punyabhorn, Chamnanphon Monpat, Thongthip Siriwan, Kittanamongkolchai Wonngarm, Townamchai Natavudh, Avihingsanon Yingyos, Udomnilobol Udomsak, Prueksaritanont Thomayant, Jianmongkol Suree, Chariyavilaskul Pajar |
| The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer. Cancer chemotherapy and pharmacology 2020 Jan . Belderbos Bodine P S, de With Mirjam, Singh Rajbir K, Agema Bram C, El Bouazzaoui Samira, Oomen-de Hoop Esther, de Wit Ronald, van Schaik Ron H N, Mathijssen Ron H J, Bins Sand |
| Biochip-based approach for comprehensive pharmacogenetic testing. Drug metabolism and personalized therapy 2020 Dec . Ikonnikova Anna Yu, Filippova Marina A, Surzhikov Sergey A, Pozhitnova Victoria O, Kazakov Ruslan E, Lisitsa Tatiana S, Belkov Sergey A, Nasedkina Tatiana |
| Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers. Cancer chemotherapy and pharmacology 2021 2 87 (6): 767-777. Kobayashi Kazuo, Sugiyama Erika, Shinozaki Eiji, Wakatsuki Takeru, Tajima Masataka, Kidokoro Hiyori, Aoyama Takeshi, Nakano Yasuhiro, Kawakami Kazuyoshi, Hashimoto Koki, Suenaga Mitsukuni, Ichimura Takashi, Ogura Mariko, Chin Keisho, Nakayama Izuma, Ooki Akira, Takahari Daisuke, Suzuki Wataru, Yokokawa Takashi, Minowa Yuichi, Hiraoka Tomoko, Suzuki Kenichi, Sato Hitoshi, Hama Toshihiro, Yamaguchi Kens |
| Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients. British journal of cancer 2021 Oct . Karas Spinel, Etheridge Amy S, Nickerson Deborah A, Cox Nancy J, Mohlke Karen L, Cecchin Erika, Toffoli Giuseppe, Mathijssen Ron H J, Forrest Alan, Bies Robert R, Innocenti Federi |
| Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes. European journal of clinical pharmacology 2021 1 77 (8): 1095-1111. Wang Tingyu, Zhou Yitian, Cao Guoshe |
| Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing. Saudi journal of biological sciences 2021 Jan 28 (1): 628-634. Aboul-Soud Mourad A M, Alzahrani Alhussain J, Mahmoud Am |
| An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer. Frontiers in pharmacology 2022 8 13 897951. Roncato Rossana, Gerratana Lorenzo, Palmero Lorenza, Gagno Sara, Poetto Ariana Soledad, Peruzzi Elena, Zanchetta Martina, Posocco Bianca, De Mattia Elena, Canil Giovanni, Alberti Martina, Orleni Marco, Toffoli Giuseppe, Puglisi Fabio, Cecchin Eri |
| Polymorphisms in solute carrier genes (SLC19A1, SLCO1B1, and SLCO1B3) predicts survival and toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of clinical pharmacy and therapeutics 2022 Jul . Sharma Parul, Singh Navneet, Sharma Siddhar |
| Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis. Clinical and translational science 2022 Jul . Guijosa Alberto, Freyria Ana, Espinosa-Fernandez Jose Rodrigo, Estrada-Mena Francisco J, Armenta-Quiroga Ana Sofía, Ortega-Treviño Maria Fernanda, Catalán Rodrigo, Antonio-Aguirre Bani, Villarreal-Garza Cynthia, Perez-Ortiz Andric |
| Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark. Breast cancer research and treatment 2022 Apr . Hjorth Cathrine F, Damkier Per, Stage Tore B, Feddersen Søren, Hamilton-Dutoit Stephen, Rørth Mikael, Ejlertsen Bent, Lash Timothy L, Ahern Thomas P, Sørensen Henrik T, Cronin-Fenton Deird |
| Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report. Pharmacogenomics and personalized medicine 2022 5 15 465-475. Jeiziner Chiara, Allemann Samuel S, Hersberger Kurt E, Meyer Zu Schwabedissen Henriette |
| Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects. Pharmacogenetics and genomics 2022 11 33 (1): 10-18. Keller Denise N, Medwid Samantha J, Ross Cameron D, Wigle Theodore J, Kim Richard |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: